Magnetic nanoparticles as bimodal tools in magnetically induced labelling and magnetic heating of tumour cells:: an in vitro study

被引:58
作者
Kettering, M.
Winter, J.
Zeisberger, M.
Bremer-Streck, S.
Oehring, H.
Bergemann, C.
Alexiou, C.
Hergt, R.
Halbhuber, K. J.
Kaiser, W. A.
Hilger, I.
机构
[1] Univ Hosp Jena, Inst Diagnost & Intervent Radiol, D-07747 Jena, Germany
[2] Inst Phys High Technol, D-07702 Jena, Germany
[3] Univ Hosp Jena, Inst Clin Chem & Lab Med, D-07740 Jena, Germany
[4] Univ Hosp Jena, Inst Anat 2, D-07743 Jena, Germany
[5] Chemicell GmbH, D-10823 Berlin, Germany
[6] Univ Erlangen Nurnberg, Dept Otorhinolaryngol Head & Neck Surg, D-91054 Erlangen, Germany
关键词
LOCOREGIONAL CANCER-TREATMENT; BIOMEDICAL APPLICATIONS; MEDICAL APPLICATION; THERMAL ABLATION; GENE DELIVERY; PARTICLES; ENHANCEMENT; TECHNOLOGY; THERAPY; FIELD;
D O I
10.1088/0957-4484/18/17/175101
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Localized magnetic heating treatments (hyperthermia, thermal ablation) using superparamagnetic iron oxide nanoparticles continue to be an active area of cancer research. The present study uses magnetic nanoparticles (MNP) as bimodal tools and combines magnetically induced cell labelling and magnetic heating. The main focus was to assess if a selective and higher MNP accumulation within tumour cells due to magnetic labelling (max. 56 and 83 mT) and consequently a larger heating effect occurs after exposure to an alternating magnetic field (magnetic heating: frequency 400 kHz, amplitude 24.6 kAm(-1)) in order to eliminate labelled tumour cells effectively. The results demonstrate that the magnetically based cellular MNP uptake by human adenocarcinoma cells is due to suitable magnetic field gradients in vitro which intensify the temperature increase generated during magnetic heating. A significantly (P <= 0.05) enhanced MNP cell uptake due to 83 mT labelling compared to controls or to 56 mT labelling was observed. Our experiments required the following conditions, namely a cell concentration of 2.5 x 10(7) cells ml(-1), a minimum MNP concentration of 0.32 mg Fe ml(-1) culture medium, and an incubation time of 24 h, to reach this effect as well as for the significantly enlarged heating effects to occur.
引用
收藏
页数:9
相关论文
共 40 条
[1]   In vitro and in vivo investigations of targeted chemotherapy with magnetic nanoparticles [J].
Alexiou, C ;
Jurgons, R ;
Schmid, R ;
Hilpert, A ;
Bergemann, C ;
Parak, F ;
Iro, H .
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 2005, 293 (01) :389-393
[2]   Magnetic Drug Targeting - A new approach in locoregional tumortherapy with chemotherapeutic agents. Experimental animal studies [J].
Alexiou C. ;
Jurgons R. ;
Schmid R. ;
Erhardt W. ;
Parak F. ;
Bergemann C. ;
Iro H. .
HNO, 2005, 53 (7) :618-622
[3]   Magnetic drug targeting - Biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment [J].
Alexiou, C ;
Jurgons, R ;
Schmid, RJ ;
Bergemann, C ;
Henke, J ;
Erhardt, W ;
Huenges, E ;
Parak, F .
JOURNAL OF DRUG TARGETING, 2003, 11 (03) :139-149
[4]   Magnetic drug targeting: biodistribution and dependency on magnetic field strength [J].
Alexiou, C ;
Schmidt, A ;
Klein, R ;
Hulin, P ;
Bergemann, C ;
Arnold, W .
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 2002, 252 (1-3) :363-366
[5]  
Alexiou C, 2000, CANCER RES, V60, P6641
[6]  
ALEXIOU C, 2004, EUR ARCH OTO-RHINO-L, V261, P148
[7]   Functionalisation of magnetic nanoparticles for applications in biomedicine [J].
Berry, CC ;
Curtis, ASG .
JOURNAL OF PHYSICS D-APPLIED PHYSICS, 2003, 36 (13) :R198-R206
[8]   MEASUREMENTS OF PARTICLE-SIZE DISTRIBUTION PARAMETERS IN FERROFLUIDS [J].
CHANTRELL, RW ;
POPPLEWELL, J ;
CHARLES, SW .
IEEE TRANSACTIONS ON MAGNETICS, 1978, 14 (05) :975-977
[9]   Recent advances in iron oxide nanocrystal technology for medical imaging [J].
Corot, Claire ;
Robert, Philippe ;
Idee, Jean-Marc ;
Port, Marc .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (14) :1471-1504
[10]   Development of tumor targeting bioprobes (111In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy [J].
DeNardo, SJ ;
DeNardo, GL ;
Miers, LA ;
Natarajan, A ;
Foreman, AR ;
Gruettner, C ;
Adamson, GN ;
Ivkov, R .
CLINICAL CANCER RESEARCH, 2005, 11 (19) :7087S-7092S